(Q35024109)

English

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

Siegfried Kasper

2

object named as

Siegfried Kasper

0 references

object named as

Heinz Grunze

1

0 references

object named as

Eduard Vieta

7

0 references

Hans-Jürgen Möller

8

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

object named as

Guy Goodwin

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

object named as

Rasmus Licht

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Charles Bowden

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

David Baldwin

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

115-124

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Lithium in the treatment of acute depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Switch from depression to mania--a record study over decades between 1920 and 1982.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

A plea for integrity of the bipolar disorder concept.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

[High dosage thyroxine treatment in therapy and prevention refractory patients with affective psychoses]

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Controlled trials in bipolar I depression: focus on switch rates and efficacy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Lithium Response in Unipolar Versus Bipolar Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Possible locus for bipolar disorder near the dopamine transporter on chromosome 5.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Newer antidepressants. Beyond selective serotonin reuptake inhibitor antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Pharmacotherapy of depression and mixed states in bipolar disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Sleep and sleep-wake manipulations in bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Bipolar mood disorder: practical strategies for acute and maintenance phase treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Forty years of lithium treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Can antidepressants cause mania and worsen the course of affective illness?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991–1997: the favourable consequences of the increasing use of SSRIs

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150612

21 January 2018

Identifiers

10.3109/15622970209150612

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35024109&oldid=2066728937"